...
机译:Ki-67,p53,表皮生长因子受体,1p36、9p21、10q23和17p13在颅底脊索瘤中的预后价值
Craig Horbinski, MD, PhD, Gerard J. Oakley, MD, Kathleen Cieply, MS, Geeta S. Mantha, PhD, Marina N. Nikiforova, MD, Sanja Dacic, MD, PhD, Raja R. Seethala, MDAccepted for publication December 4, 2009.From the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.The authors have no relevant financial interest in the products or companies described in this article.Presented in part at the annual meeting of the United States and Canadian Academy of Pathology, Boston, Massachusetts, March 9, 2009.Reprints: Raja Seethala, MD, Presbyterian University Hospital, Department of Pathology, A616.3, 200 Lothrop St, Pittsburgh, PA 15213 (e-mail: seethalarr@upmc.edu).,;
机译:Ki-67,p53,表皮生长因子受体,1p36、9p21、10q23和17p13在颅底脊索瘤中的预后价值。
机译:大肠癌中多种蛋白表达作为预后因素:组织蛋白酶D,p53,COX-2,表皮生长因子受体,C-erbB-2和Ki-67
机译:MIB-1,p53,表皮生长因子受体和INI1在儿童脊索瘤中的预后价值
机译:表皮生长因子受体酪氨酸激酶抑制剂ZD1839(Iressa)通过独立于p53和MMP,uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
机译:表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
机译:KI-67P53EGFR1P369P2110Q23和17P13在颅底脊索瘤的预后值
机译:多种蛋白质作为结肠直肠癌的预后因子的表达:组织蛋白酶D,P53,COX-2,表皮生长因子受体,C-ERBB-2和Ki-67
机译:乳腺癌:表皮生长因子受体,mDm2和p53突变的参与